IP Library Granted Patent US 8,084,224
Granted Patent B2
US 8,084,224 · App. 12/754,317 · Granted Dec 27, 2011

Methods for improving the recovery of troponin I and T in membranes, filters and vessels

Assignee: Alere San Diego, Inc.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,084,224
App. No.
12/754,317
Granted
Dec 27, 2011
Kind
B2
Abstract

A method to facilitate recovery troponin I and/or troponin T from a sample comprising addition of troponin C to the sample or to a surface from which the troponin I and/or troponin T are recovered.

Claims (14)

1. A method for diagnosing heart muscle damage, comprising:

performing an immunoassay to determine the amount of cardiac troponin I in a sample from a subject, by combining

a) an antibody conjugate comprising a signal generating element and a first antibody that specifically binds to cardiac troponin I complexed with troponin C and troponin T and specifically binds to free cardiac troponin I; and

b) said sample, thereby forming a reaction mixture comprising said antibody conjugate bound to said cardiac troponin I, if present, in said sample;

applying said reaction mixture to a surface comprising a second antibody capable of specifically binding to cardiac troponin I;

capturing said cardiac troponin I—antibody conjugate complex on said surface via said second antibody, whereby the captured complex produces a detectable signal;

detecting said signal;

relating said signal to the amount of troponin I present in the sample, wherein said immunoassay is configured to provide assay results that are within a factor of two for (i) cardiac troponin I, uncomplexed to either troponin T or troponin C; and (ii) an equivalent concentration of cardiac troponin I in a complex with troponin T and troponin C and;

relating the amount of cardiac troponin I present in the sample to the occurrence or nonoccurrence of heart muscle damage.

2. The method of claim 1 , wherein said sample is whole blood, plasma or serum.

3. The method of claim 1 , wherein said first antibody yields an assay response for oxidized cardiac troponin I, reduced cardiac troponin I and cardiac troponin I in complex with troponin C and troponin T that is within 20% of an assay response for an equivalent concentration of oxidized cardiac troponin I alone, reduced troponin I alone, and said complexed troponin I alone.

4. The method of claim 1 , wherein said first antibody, said second antibody, or both, is a monoclonal antibody.

5. The method of claim 1 , wherein said second antibody specifically binds to cardiac troponin I complexed with troponin C and troponin T and specifically binds to free cardiac troponin I.

6. The method of claim 1 , 2 , 3 , 4 or 5 , wherein the heart muscle damage is myocardial infarction.

Assignments (7)
RELEASE OF SECURITY INTEREST IN INTELLECTUAL PROPERTY RECORDED AT REEL 036994, FRAME 0192 AND REEL 037115, FRAME 0498 Recorded Oct 5, 2017
From: HEALTHCARE FINANCIAL SOLUTIONS, LLC, AS COLLATERAL AGENT
To: ALERE CONNECT, LLC; ALERE SAN DIEGO, INC. (FKA BIOSITE INC. OR FKA CHOLESTECH CORP. OR FKA HEMOSENSE INC. OR FKA INVERNESS MEDICAL-BIOSTAR INC. OR FKA ISCHEMIA TECHNOLOGIES, INC. OR FKA TWISTDX, INC.); ALERE SCARBOROUGH, INC. (FKA MATRITECH, INC. FKA ADVANTAGE DIAGNOSTICS CORP. OR FKA BINAX, INC. OR FKA MILANO ACQUISITION CORP.); INNOVACON, INC. (FKA APPLIED BIOTECH, INC. OR FKA AMEDITECH INC.); IONIAN TECHNOLOGIES, LLC (FKA IONIAN TECHNOLOGIES, INC.); QUALITY ASSURED SERVICES INC. (FKA ZYCARE INC.); STANDING STONE, LLC; ESCREEN, INC.
Reel/Frame 044213/0258 →
ASSIGNMENT OF IP SECURITY AGREEMENT, PREVIOUSLY RECORDED AT REEL 036994, FRAME 0192 Recorded Nov 16, 2015
From: GENERAL ELECTRIC CAPITAL CORPORATION, AS RETIRING ADMINISTRATIVE AGENT
To: HEALTHCARE FINANCIAL SOLUTIONS, LLC, AS SUCCESSOR ADMINISTRATIVE AGENT
Reel/Frame 037115/0498 →
INTELLECTUAL PROPERTY SECURITY AGREEMENT Recorded Oct 29, 2015
From: ALERE CONNECT, LLC; ALERE SAN DIEGO, INC. (FKA BIOSITE INC. OR FKA CHOLESTECH CORP. OR FKA HEMOSENSE INC. OR FKA INVERNESS MEDICAL-BIOSTAR INC. OR FKA ISCHEMIA TECHNOLOGIES, INC. OR FKA TWISTDX, INC.); ALERE SCARBOROUGH, INC. (FKA MATRITECH, INC. FKA ADVANTAGE DIAGNOSTICS CORP. OR FKA BINAX, INC. OR FKA MILANO ACQUISITION CORP.); INNOVACON, INC. (FKA APPLIED BIOTECH, INC. OR FKA AMEDITECH INC.); IONIAN TECHNOLOGIES, LLC (FKA IONIAN TECHNOLOGIES, INC.); QUALITY ASSURED SERVICES INC. (FKA ZYCARE INC.); STANDING STONE, LLC; ESCREEN, INC.
To: GENERAL ELECTRIC CAPITAL CORPORATION, AS COLLATERAL AGENT
Reel/Frame 036994/0192 →
NOTICE OF RELEASE OF SECURITY INTEREST IN PATENTS RECORDED AT REEL 026557 FRAME 0287 Recorded Jun 23, 2015
From: GENERAL ELECTRIC CAPITAL CORPORATION, AS ADMINISTRATIVE AGENT AND COLLATERAL AGENT
To: ADVANTAGE DIAGNOSTICS CORPORATION; ALERE MEDICAL, INC.; ALERE SAN DIEGO, INC.; ALERE SCARBOROUGH, INC.; AMEDITECH INC.; APPLIED BIOTECH, INC.; BINAX, INC.; BIOSITE INCORPORATED; CHOLESTECH CORPORATION; GENECARE MEDICAL GENETICS CENTER, INC.; HEMOSENSE, INC.; INSTANT TECHNOLOGIES, INC.; INVERNESS MEDICAL - BIOSTAR INC.; ISCHEMIA TECHNOLOGIES, INC.; MATRITECH, INC.; MATRIA HEALTHCARE, INC.; ZYCARE, INC.
Reel/Frame 036011/0581 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 30, 2011
From: BUECHLER, KENNETH F.; MCPHERSON, PAUL H.
To: BIOSITE INCORPORATED
Reel/Frame 026995/0816 →
CHANGE OF NAME Recorded Sep 30, 2011
From: BIOSITE INCORPORATED
To: ALERE SAN DIEGO, INC.
Reel/Frame 026995/0884 →
SECURITY AGREEMENT Recorded Jul 7, 2011
From: ADVANTAGE DIAGNOSTICS CORPORATION; ALERE MEDICAL INCORPORATED; ALERE SAN DIEGO, INC.; ALERE SCARBOROUGH, INC.; AMEDITECH INC.; APPLIED BIOTECH, INC.; BINAX, INC.; BIOSITE INCORPORATED; CHOLESTECH CORPORATION; GENECARE MEDICAL GENETICS CENTER, INC.; HEMOSENSE, INC.; INSTANT TECHNOLOGIES, INC.; INVERNESS MEDICAL - BIOSTAR INC.; ISCHEMIA TECHNOLOGIES, INC.; MATRITECH, INC.; ZYCARE INC.; MARTIA HEALTHCARE, INC.
To: GENERAL ELECTRIC CAPITAL CORPORATION
Reel/Frame 026557/0287 →
Continuity (5)
Continuation 11673397 · Feb 9, 2007
Division 10459006 · Jun 10, 2003
Division 08769077 · Dec 18, 1996
Continuation In Part 08423582 · Apr 18, 1995
Related Publication 20110014629A1 · Jan 20, 2011